This document provides an overview of Kuwait Life Sciences Company (KLSC) and its subsidiaries which were established to stimulate the life sciences sector in the Middle East and North Africa region. KLSC is fully owned by NTEC, the technology transfer arm of the Kuwait Investment Authority. It has established five platform companies focused on pharmaceutical commercialization, medical devices, clinical research, healthcare training, and active pharmaceutical ingredients. The platforms work with world-class partners and have expanded operations across the MENA region since 2010. KLSC also invests in healthcare and life sciences funds and companies internationally.
This Power Point Presentation is about the health care industry its opportunities in growing market and the company profile and swot analysis of Apollo Hospitals
This Power Point Presentation is about the health care industry its opportunities in growing market and the company profile and swot analysis of Apollo Hospitals
Apollo hospital, it's management philosophy, strategies, management issues, challenges faced by management and overcome activities with expansion plan and licensing.
AHMC’s successful track record includes collaboration in more than 50 hospitals and projects spanning 24 countries around the world. AHMC’s hospital network consists of 32 hospital and healthcare centers, among them 13 operational facilities consisting of nearly 3,000 beds, 2,200 physicians and 5,500 employees which it has either invested in or currently manages.
Innovation in medical device and diagnostic industry at India Leadership Conc...Indian Affairs
Conceptualized& instituted in the year by India’s most respected journalist Satya Brahma, India Leadership Conclave Awards are are meant to highlight & celebrate those individuals & companies who’ve ascended to the top of their business against all odds. Currently celebrating its 9th successful annual editions, iconic figures such as Ratata Tata, MukeshAmbani, Naresh Goyal, Narayan Murthy, Shiv Nadar,SudhaMurthy,Priyanka Chopra, Manish Malhotra, Neeta Lulla, Late Yash Chopra, Govinda, Rani Mukerjee, Sushimita Sen, Karishma Kapoor are some of its proud recipients. Being India’s most iconic leadership awards having a tremendous impact on the credibility of the Group, India Leadership Conclave jury takes every steps to ensure fair, credible & independent selection process,.The nomination categories, eligibility criteria, selection process & evaluation criteria constitute the core areas of research. Public voting constitutes its biggest parameters. Physical interviews by Network 7 Media Group Journalists on ground on each nominee are conducted followed by Jury’s strong analytical verdict. The set of awards developed by the Board Members of the Network 7 Media Group is to propel the talent engine & encourage, motivate the innovative entrepreneurs. These leadership awards are aimed at empowering the leaders who think differently.This recognition voted by the people of india& subsequent by Jury Board reflect the Winner’s remarkable achievement & accomplishments as a leader of substance driven by passion, initiative & commitment to deliver excellence. India Leadership Conclave Awards are special as we don’t follow any traditional guidelines, defy conventions & crown winners based on innovations, merit & competence. Our decision is based on number of factors which are transparent, robust & driven by extensive research.
Thyrocare Technologies Limited claims to be India’s most advanced totally automated laboratory having its strong presence in more than 2000 cities / towns in India and internationally.
The company was started in 1996, by Dr Velumani Arokiaswamy with a staff of 4 people, with focus on low cost Thyroid testing.
By 2014, it has become India’s most profitable diagnostic business. The company has a highly differentiated business model. It is more of a B2B company, collecting samples from hundreds of dedicated collection points, and also from allied labs. All processing is done in one highly automated lab near Mumbai.
The Inova Personalized Health Accelerator (IPHA) is dedicated to finding and enabling the next generation of medical technology and healthcare start-ups seeking to enhance patient care, predict and prevent disease, lower healthcare costs, and improve health outcomes. Our goal is to partner with entrepreneurs to bring the most promising healthcare innovations to market. Working closely together, we can quickly achieve significant milestones in value creation and risk mitigation for our partner companies.
Global Venture Capital / Private Equity deals in Healthcare / Lifescience sec...India Business Reports
We recorded 50 transactions for June 2018, aggregating to a sum of USD 1.85B. Of these, just over USD1B, amounting to 58% of total deal amount, were reported for US based companies. China recorded around USD450m, or about 25% of total investment. Rest of the world accounted for less than 20%.
Around 60% of investments, spread over 20 transactions, went into supporting R&D stage companies, while the remaining went into healthcare service companies, digital health companies and health-tech providers. In India only 2 deals happened – one in services and another in devices space.
The largest deal was China’s I Mab, which completed a Series C financing for $220 million, representing one of the largest amounts ever raised in Series C by an innovative biotech company in China. I Mab focusses on innovative biologics in therapeutic areas of immuno-oncology and immuno-inflammation.
There were 4 other transactions above USD100: Precision Bioscience, USA; CMR Surgical, UK; Paladina Health, USA; and Stealth Biotherapeutics, USA
The Business Fame Magazine is honored to present “The Most Prominent Healthcare Solution Providers In 2021” which are adapting novel technologies to meet and exceed the health care standard.
Apollo hospital, it's management philosophy, strategies, management issues, challenges faced by management and overcome activities with expansion plan and licensing.
AHMC’s successful track record includes collaboration in more than 50 hospitals and projects spanning 24 countries around the world. AHMC’s hospital network consists of 32 hospital and healthcare centers, among them 13 operational facilities consisting of nearly 3,000 beds, 2,200 physicians and 5,500 employees which it has either invested in or currently manages.
Innovation in medical device and diagnostic industry at India Leadership Conc...Indian Affairs
Conceptualized& instituted in the year by India’s most respected journalist Satya Brahma, India Leadership Conclave Awards are are meant to highlight & celebrate those individuals & companies who’ve ascended to the top of their business against all odds. Currently celebrating its 9th successful annual editions, iconic figures such as Ratata Tata, MukeshAmbani, Naresh Goyal, Narayan Murthy, Shiv Nadar,SudhaMurthy,Priyanka Chopra, Manish Malhotra, Neeta Lulla, Late Yash Chopra, Govinda, Rani Mukerjee, Sushimita Sen, Karishma Kapoor are some of its proud recipients. Being India’s most iconic leadership awards having a tremendous impact on the credibility of the Group, India Leadership Conclave jury takes every steps to ensure fair, credible & independent selection process,.The nomination categories, eligibility criteria, selection process & evaluation criteria constitute the core areas of research. Public voting constitutes its biggest parameters. Physical interviews by Network 7 Media Group Journalists on ground on each nominee are conducted followed by Jury’s strong analytical verdict. The set of awards developed by the Board Members of the Network 7 Media Group is to propel the talent engine & encourage, motivate the innovative entrepreneurs. These leadership awards are aimed at empowering the leaders who think differently.This recognition voted by the people of india& subsequent by Jury Board reflect the Winner’s remarkable achievement & accomplishments as a leader of substance driven by passion, initiative & commitment to deliver excellence. India Leadership Conclave Awards are special as we don’t follow any traditional guidelines, defy conventions & crown winners based on innovations, merit & competence. Our decision is based on number of factors which are transparent, robust & driven by extensive research.
Thyrocare Technologies Limited claims to be India’s most advanced totally automated laboratory having its strong presence in more than 2000 cities / towns in India and internationally.
The company was started in 1996, by Dr Velumani Arokiaswamy with a staff of 4 people, with focus on low cost Thyroid testing.
By 2014, it has become India’s most profitable diagnostic business. The company has a highly differentiated business model. It is more of a B2B company, collecting samples from hundreds of dedicated collection points, and also from allied labs. All processing is done in one highly automated lab near Mumbai.
The Inova Personalized Health Accelerator (IPHA) is dedicated to finding and enabling the next generation of medical technology and healthcare start-ups seeking to enhance patient care, predict and prevent disease, lower healthcare costs, and improve health outcomes. Our goal is to partner with entrepreneurs to bring the most promising healthcare innovations to market. Working closely together, we can quickly achieve significant milestones in value creation and risk mitigation for our partner companies.
Global Venture Capital / Private Equity deals in Healthcare / Lifescience sec...India Business Reports
We recorded 50 transactions for June 2018, aggregating to a sum of USD 1.85B. Of these, just over USD1B, amounting to 58% of total deal amount, were reported for US based companies. China recorded around USD450m, or about 25% of total investment. Rest of the world accounted for less than 20%.
Around 60% of investments, spread over 20 transactions, went into supporting R&D stage companies, while the remaining went into healthcare service companies, digital health companies and health-tech providers. In India only 2 deals happened – one in services and another in devices space.
The largest deal was China’s I Mab, which completed a Series C financing for $220 million, representing one of the largest amounts ever raised in Series C by an innovative biotech company in China. I Mab focusses on innovative biologics in therapeutic areas of immuno-oncology and immuno-inflammation.
There were 4 other transactions above USD100: Precision Bioscience, USA; CMR Surgical, UK; Paladina Health, USA; and Stealth Biotherapeutics, USA
The Business Fame Magazine is honored to present “The Most Prominent Healthcare Solution Providers In 2021” which are adapting novel technologies to meet and exceed the health care standard.
We are driven by a passionfor transforming products into brands and patients into survivors. Navicor is a 100% healthcare-focused, full-service agency that understands the unique aspects of the oncology marketplace. We have extensive oncology launch experience and have partnerships with large and small pharma and biotech companies.
The external healthcare environment is changing rapidly and providers are under increasing pressure to innovate with increasing speed and efficiency.
Be it experimenting with new care delivery models to improve care coordination, redesigning workflows to enhance efficiency, or developing new products that improve clinical outcomes, hospitals and their service lines are looking for effective ways to harness the creative power of physicians and employees to solve problems that matter. However, few organizations innovate in an orderly, reliable way.
Great ideas remain captive in the heads of physicians and employees and one-off attempts to spur innovation through “hack-a-thons” and “pitch days” prove disappointing. As an academic medical center and a world leader in orthopedics, Hospital for Special Surgery has a long history of results-oriented innovation.
In this webinar, we will share:
– HSS’ systematic approach for driving innovation
– strategies for generating new insights and developing novel solutions
– processes for piloting and testing new ideas
– guiding principles for creating a culture of innovation
– advice on how to build your very own innovation infrastructure
About the Speaker:
Mark Angelo is Vice President, Innovation & Business Development for Hospital for Special Surgery. Mark joined HSS in 2009 and has held various senior management positions at the Hospital across operations, strategy and business development. As Vice President, Innovation & Business Development, Mark is responsible for advancing hospital strategic priorities related to quality and efficiency, innovation, growth and diversification. One of his key responsibilities includes leading the Operational Excellence program, a hospital-wide initiative that leverages industrial engineering principles to maximize quality and efficiency. Mark also leads the HSS Innovation Center whose mission is to support the development and commercialization of early-stage technologies and solutions.
Prior to joining HSS, Mark worked as a management consultant for Monitor Group where he specialized in operations strategy and organizational design. Mark holds a Bachelor of Applied Science in Biomedical Engineering from the University of Toronto and a Master of Business Administration from Harvard Business School.
The 10 Most Admired Diagnostics Center in IndiaMerry D'souza
The 10 Most Admired Diagnostics Center in India". This issue features a handful of exceptional organizations that offer a diverse and engaging mix of creativity and distinctiveness in their services. On the Cover of the issue, we have showcased Premier Health Center. PHC is one of the most trusted diagnostic centers in India.
10 Most Innovative CRO’s To Watch In 2022.pdfinsightscare
During the COVID-19 pandemic, if clinicians, healthcare service-providing staff, nurses, and doctors were battling at the forefront, then the Clinical Research Organizations (CROs) have been working hard
The 10 Leading Hospital Management Solution | Insights Careinsightscare
The 10 leading hospital management solution ,these industry leaders continue to embrace the rapid change in the healthcare industry & develop solutions to meet its rising demands.
Europe's Top 5 Effective Leaders in Healthcare Edition.pdfinsightscare
Insights Care’s team carried out its own research and found the ‘Europe's Top 5 Effective Leaders in Healthcare,’ and depicted their revolutionary tales
2. KLSC is fully owned by NTEC, the technology transfer arm of the Kuwait
Investment Authority
World’s First Sovereign Wealth Fund
Established in 1953
>550 bn USD in AUM
Created by Kuwait’s Council of Ministers
Established in 2005
Fully owned by the KIA
100 mn KD or ~ $350 mn paid up capital
Five fully owned subsidiary companies:
Clean and
Alternative Energy
Investments
Life Sciences and
Healthcare
Investments
ICT and Mobile
Technology
Investments
Strategic and
Technology
Advisory Services
Human Capital
Development Solutions
and HR Services
3. From 2006 to 2009, prior to KLSC establishment, NTEC Life Sciences team
developed its relationships and cemented its strategy
The KLSC team studied and analyzed the
Life Sciences Sector in MENA…
…and developed a strategy to develop unique platforms that
would catalyze technology transfer to the region
The NTEC Life Sciences team developed strong relationships
with leading International
Industry Pioneers and Investors
Technology InvestorsTechnology Pioneers
Knowledge Transfer Platform
Pharmaceutical
Commercialization
Platform
Medical Devices
Commercialization
Platform
Industrial
(Specialty Chemicals)
Platform
Clinical
Research (CRO)
Platform
Starting in 2010, operational strategy started implementation
4. Building on the aforementioned strategy, KLSC developed five individual
platform companies to stimulate the life sciences sector in MENA
Operational in 2010
Fully owned by the NTEC
15 mn KD or ~ $53 mn paid up capital
Five platform companies in life sciences:
MENA’s leading
Contract Resource
Organization
Medical Devices and
Consumables
Distribution
MENA’s First
Life Science Focused
Training Academy
MENA’s Premiere
Active Pharmaceutical
Ingredients Producer
Leading Pharmaceutical
Licensor for the Middle
East and Africa
5. World Class Partners:
The Why?
NewBridge aims to improve the access for ‘big pharma’ companies, genomics and biologics
manufacturers to the MENA region
The How?
NewBridge pharmaceuticals is a regional specialty company providing one-stop-solution to
pharmaceuticals, biological, genomics and other innovative healthcare companies
The What?
NewBridge is the exclusive licensor of pharmaceutical products in:
Oncology Immunology Nutrition
Astral®, Aware®, Clasteon™, Halaven® Cimzia® Celia®, Delicel®,
M2PK®, Oncotype Dx®, Sancuso® RealDiet™, Taranis®
CNS Care Dermatology Metabolic Care Woman’s Health
Neupro®, Vimpat® Ebenet® Diabase® Glinconorm®, Pylera® Femmed®,Verifi®
Joe Henein, President and CEO
Former VP & Managing Director ME/Africa - Wyeth
Former VP & Therapeutic Area Head – Women Heath
Former VP & Global Therapeutic Commercial Chair -
Wyeth
A leading MENA pharmaceutical licensor
Anchored in 2011 Venture Capital
Regional Footprint
6. The Why?
Innomedics aims to improve the efficiency of the healthcare system and encourage value based
medicine by providing the most efficient and best value medical equipment and consumables
The How?
Innomedics delivers innovative personalized health and mobile health products directly to the
consumers via partnerships with local pharmacy and retail distributors
The What?
Innomedics is a regional distributor of medical equipment in the GCC region that provides innovative
medical products and consumables to both government and private sector healthcare service
providers
Dr. Zahran Ahmed, Sales Director
Total 20 years experience in medical devices distribution
Director of Medical &Scientific Division, Al -Hajery & Sons
Sales supervisor Bristol-myers SquibbA leading GCC focused medical devices
and consumables distribution company
Incubated in 2011 Venture Capital
Innovative Medical Products
World Class Partners and Agencies:
7. The Why?
Clinart hopes to improve the ability for big pharma companies and governments to host world-class
clinical trials in the MENA region
The How?
Clinart provides quality services with a proven track record of successful trials in the region (phase II-
IV) since 2001
The What?
Clinart MENA is a Full Service Contract Research Organization (CRO) headquartered in Dubai Health
Care City, that brings Clinical Research expertise to the Middle East region in line with local cultures
and customs
Dr. Alaa Assem, President and CEO
20 years experience in MENA with Sandoz, Lilly, Wyeth,
Pfizer
M.Sc in Ophthalmology from University of Alexandria
MBA from Maastricht School of Management
(Netherlands)
Invested in 2012 Growth Capital
Experience by TherapeuticArea
World Class Partners and Clients:
Over 8,000 Patient’s Recruited for
Non-Interventional Studies
A leading MENA focused CRO
8. The Why?
LSA aims to develop healthcare professionals knowledge, practice, and clinical outcome
LSA believes in transforming healthcare leaders to advance the system & inspire change
The How?
LSA has prestigious affiliations with international top ranked medical universities to provide state-
of-the-art training programs which are accredited and recognized for its value & impact
LSA also collaborates with regional & local experts to share latest practices in their field
The What?
Unique platform for Continuous Professional Development (CPD) programs, Continuous Medical
Education (CME), and Evidence-based Professional Development (EPD)
In 2014, LSA has offered +70 various training programs to +700 participants
In 2015, LSA plans to conduct 85 programs and opens its training facility in March 2015
First Healthcare Training App in GCC
Ph. Mohammad Nahis Al Anzi, CEO
Former COO at Kuwait Life Sciences Company
MBA, Maastricht School of Management,
B.Sc, Pharmacy, University of Sunderland
Certified Professional Coach, ICF
The First Healthcare Academy in the GCC
Incubated in 2013 Venture Capital
World Class Partners:
9. The Why?
eCore aims to improve access for pharmaceutical manufacturers to best in class APIs at a
reasonable value proposition
The How?
eCore is focused on commercial and representation services in the field of industrial chemicals for
the Middle East and Africa region, across multiple industries including Food, Feed,
Pharmaceuticals, Paints, and home care
The What?
eCore is involved in:
Representation services - for reputable suppliers to develop their business in the MENA market
Importation and Distribution services
Exportation services - to support local MENA companies in identifying new export opportunities
for their products
Eng. Wael Gaama, CEO
30 years of experience in API industry with Ciba-Geigy,
Rhone, Poulenc/Rhodia
MBA, Ecole des HEC - Universite de Lausanne
BS, Faculty of Engineering - University of AlexandriaMENA’s Premiere Manufacturer of
Active Pharmaceutical Ingredients (APIs)
Added in 2014 Growth Capital + Exit for Existing Partner
A Diversified Echelon of Clients Across Multiple Industries:
Regional Footprint
10. KLSC is also an investor in multiple healthcare and life science funds
and companies across the world
Investment Location Description
“KLSC invests between 3 to 5 mn USD for Significant Minority Shares in Revenue generating
companies that are ideally looking for a commercial partner for MENA”
LP in Burrill Life Sciences Capital Fund III
300 mn USD fund focused on life sciences
Investments include: Acusphere, Ceptanis, Gevo, Taiwan Liposome,
Neos Therapeutics, Nevotech, Nova Therapeutics, OcooGenex, Novadaq
Technologies,Vividia, Waterstone Pharmaceuticals, Wellpartner Inc.
LP in WP Venture IV Life Science Fund
100 mn USD fund focused on life sciences
Investments include: Genticel, Middle Peak, Immatics, Neuway Pharma,
Rigontec, Definiens, ImevaX
San Francisco, USA
Germany
Birmingham, UK
Indirect(Funds)Direct
Aix-en-Provence, France
Quanta is focused on the development and commercialisation of a novel
cartridge-based haemodialysis system named SC+
SC+ is the only high performance, portable, compact haemodialysis system
with the clinical efficacy and high flow rates of traditional in-centre machines
The only ultrasound system with an UltraFast™ platform
This SuperSonic speed enables innovations such as ShearWave™
Elastography and UltraFast™ Doppler while rendering clinically detailed
B-mode image quality for all clinical applications
Valbonne, France Provides advanced medical imaging products and services for
diagnosing and monitoring cancer patients in both routine clinical
practice and clinical drug development
11. Innovative Investments
Advancing Healthcare
THANK YOU
KIPCO Tower, 27th Floor, Al Shuhadaa St., Sharq
P.O. Box 25363, Safat 13114, Kuwait
Tel : +965 22215622
Fax: +965 2249 0959
www.klsc.com.kw
Thank you and Enjoy the Dinner